Alnylam Pharmaceuticals
ALNY
#518
Rank
โ‚น4.204 T
Marketcap
โ‚น31,825
Share price
0.05%
Change (1 day)
34.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company